Epilepsy Action news archive
Brexit and epilepsy – where are we now?
Epilepsy Action news archive
Draft NICE cannabis-based medicines guidance
Epilepsy for professionals
Valproate utilisation trends among girls and women
Epilepsy Action news archive
Failings in treatment of people with neuro conditions
Epilepsy Action news archive
Disabled people four times worse off financially
Epilepsy for professionals
A pharmacist implemented educational treatment programme
Epilepsy Action news archive
Exposure to topiramate and valproate linked to birth defects
Epilepsy Action news archive
WHO calls for action around epilepsy
Epilepsy Action news archive
Risk of behavioural problems higher in children exposed to epilepsy medicines
Page 50 of 64